Effects of Exercise Intervention and Rehabilitation Exercise Intervention in Patients With Type 2 Diabetes

NCT01393275 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2011-11-08

No results posted yet for this study

Summary

The purposes of the study are

* to determine if a supervised exercise intervention is improving the metabolic parameters in type 2 diabetes patients
* to investigate what kind of intervention (strength endurance training versus combined strength endurance training and rehabilitation exercise intervention)is more effective in improving the metabolic parameters in patients with type 2 diabetes
* to assess which exercise intervention induces higher effects to the metabolic rate and cardiac and pulmonary capacity
* to investigate what kind of intervention includes highest effects in long term persistence of these positive effects

Conditions

  • Diabetes
  • Diabetes Mellitus, Non-Insulin-Dependent

Interventions

OTHER

rehabilitation exercise intervention

exercise intervention: 15 minutes warm up, 30 minutes strength endurance training, 60 minutes rehabilitation exercise training - once a week 15 minutes warm up, 30 minutes strength endurance training - once a week

OTHER

placebo control group

exercise intervention: 15 minutes warm up, 30 minutes strength endurance training, 5 minutes walking 55 minutes conversation in the group- once a week 15 minutes warm up, 30 minutes strength endurance training - once a week

Sponsors & Collaborators

  • Sportpark Zwickau, Germany

    collaborator UNKNOWN
  • Sportpark Glauchau, Germany

    collaborator UNKNOWN
  • Comenius University

    collaborator OTHER
  • University of Giessen

    lead OTHER

Principal Investigators

  • Andree Hillebrecht, Dr. med. · University of Giessen

  • Dusan Hamar, Prof. Dr. · Comenius University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2010-11-30
Completion
2011-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01393275 on ClinicalTrials.gov